Tram Bui

Tram Bui

Investor Relations Contact chez HALOZYME THERAPEUTICS, INC.

Health Technology
Commercial Services
Finance

Profil

Tram Bui is currently the VP-Investor Relations & Corporate Communications at Halozyme Therapeutics, Inc. Prior to this, she was the Vice President-Communications & Investor Relations at Antares Pharma, Inc. from 2020 to 2022.
She also worked as an Account Director-Investor Relations at KCSA Strategic Communications in 2014-2015 and as a Vice President-Investor Relations at The Ruth Group, Inc. She was also an Equity Analyst at Lazard Asset Management LLC.
Ms. Bui completed her undergraduate degree at the University of New Orleans.

Postes actifs de Tram Bui

SociétésPosteDébut
HALOZYME THERAPEUTICS, INC. Investor Relations Contact 01/01/2022
Tous les postes actifs de Tram Bui

Anciens postes connus de Tram Bui

SociétésPosteFin
ANTARES PHARMA, INC. Investor Relations Contact 01/05/2022
Public Communications Contact 01/09/2015
Analyst-Equity 31/01/2009
Public Communications Contact -
Voir l'expérience en détail de Tram Bui

Formation de Tram Bui

University of New Orleans Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Tram Bui

Relations

23

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
HALOZYME THERAPEUTICS, INC.

Health Technology

Entreprise privées4

Health Technology

Finance

Commercial Services

Commercial Services

Voir les connexions sociétés